Rajan Sharma
Stock Analyst at Goldman Sachs
(0.26)
# 4,237
Out of 4,941 analysts
5
Total ratings
25%
Success rate
-13.93%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rajan Sharma
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Reinstates: Sell | $7.25 | $9.81 | -26.10% | 1 | May 29, 2025 | |
| AZN AstraZeneca | Initiates: Buy | $97 | $75.34 | +28.75% | 1 | May 30, 2024 | |
| GSK GSK plc | Initiates: Neutral | $47 | $38.22 | +22.97% | 1 | May 30, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $31.87 | +147.88% | 2 | Jun 20, 2023 |
DBV Technologies
May 29, 2025
Reinstates: Sell
Price Target: $7.25
Current: $9.81
Upside: -26.10%
AstraZeneca
May 30, 2024
Initiates: Buy
Price Target: $97
Current: $75.34
Upside: +28.75%
GSK plc
May 30, 2024
Initiates: Neutral
Price Target: $47
Current: $38.22
Upside: +22.97%
Immunocore Holdings
Jun 20, 2023
Reiterates: Overweight
Price Target: $79
Current: $31.87
Upside: +147.88%